Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIP-A: Apremilast on Vascular Inflammation in Psoriasis
NCT03082729Phase 4Completed
- Sponsor
- University of Pennsylvania
- Start
- Apr 2017
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apremilast in psoriasis, sponsored by University of Pennsylvania. Started Apr 2017; status: completed.
02
Drugs
apremilast
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT03082729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03082729.